NAD+ Redox Biology and the NAD+/NADH Ratio
Two different redox couples, often confused
NAD+/NADH and NADP+/NADPH are two distinct redox couples — pairs of oxidized and reduced forms of a molecule that can accept or donate electrons — and they are not interchangeable, despite differing by only a single phosphate group.[1] Oxidation is the loss of electrons; reduction is the gain of electrons; the two always happen together, which is why these are called redox (reduction-oxidation) reactions. NAD+ is reduced to NADH by picking up electrons during catabolic reactions that break molecules down for energy; NADH is oxidized back to NAD+ when it donates those electrons onward, mainly in the electron transport chain. NADP+ and NADPH run largely separate biology: cells generate NADPH mainly through the oxidative pentose phosphate pathway, and use it predominantly for reductive biosynthesis (building molecules like fatty acids and nucleotides) and for antioxidant defense, donating electrons to regenerate reduced glutathione and thioredoxin.[2] A supplement or intervention that raises NAD+ is not thereby shown to raise NADPH, and the reverse is equally true — these are separate pools serving separate purposes.
Where NAD+/NADH does its work
NAD+ accepts electrons during glycolysis (in the cytosol) and during the TCA cycle (inside mitochondria), becoming NADH each time.[3] That NADH then donates its electrons to Complex I of the electron transport chain, embedded in the inner mitochondrial membrane, which uses the resulting electron flow to help generate ATP through oxidative phosphorylation. This is the core reason NAD+ availability is described as connected to cellular energy production: it's not that NAD+ itself is an energy source, but that a shortage of oxidized NAD+ available to accept electrons can bottleneck the catabolic reactions that feed the electron transport chain.
The ratio matters more than the raw amount
The NAD+/NADH ratio — not the absolute quantity of either molecule alone — is what determines whether a given redox-dependent reaction can proceed, and that ratio is compartment-specific, pathway-specific, and constantly changing rather than a single fixed number for a cell.[1] One commonly used proxy for the cytosolic NAD+/NADH ratio is the lactate-to-pyruvate ratio, because the enzyme lactate dehydrogenase keeps that reaction close to equilibrium with the surrounding NAD+/NADH pool — but it is a proxy for one compartment, not a universal readout, and it doesn't capture the mitochondrial ratio. Because the inner mitochondrial membrane doesn't allow NAD+ or NADH to cross it directly, cells use indirect shuttle systems — chiefly the malate-aspartate shuttle and the glycerol-3-phosphate shuttle — to move the electrons carried by cytosolic NADH into the mitochondrial matrix without moving the NADH molecule itself, which is one of the mechanistic reasons the cytosolic and mitochondrial NAD+/NADH ratios can differ substantially from each other at the same moment in the same cell.[3]
Why "more NAD+ is always better" is scientifically misleading
This hub deliberately avoids that framing, for three concrete reasons. First, raising total or whole-cell NAD+ does not specify what happens to the ratio in any one compartment — a rise in total NAD+ could in principle coincide with an unchanged or even more reduced ratio somewhere inside the cell, and no human NMN trial has measured compartment-specific ratios directly (see NAD+ Compartmentalization). Second, NAD+-consuming enzymes such as sirtuins, PARPs, and CD38 each respond to local NAD+ availability in their own compartment and context, not to a single global number (see NAD+ and Sirtuins and NAD+ and PARPs). Third, the ratio is measured very differently by different techniques — older enzymatic assays and newer direct LC-MS methods have produced substantially different values for the same tissue (see The NAD+ Metabolome) — so comparing ratio claims across studies requires knowing how each one was measured.
Consumer phrases this hub avoids
Phrases like "better redox balance" and "optimized cellular energy" are common in NMN marketing but are too vague to correspond to a specific, measurable claim: "balance" and "optimized" are not defined redox parameters, and no human NMN trial has measured a defined redox endpoint (such as a validated compartment-specific NAD+/NADH ratio) as a primary outcome. Where this hub discusses NAD+'s role in energy metabolism, it describes the specific established mechanism above rather than these consumer shorthand phrases.
Related reading
For NAD+'s specific role in mitochondrial energy production, see NAD+, Mitochondria, and Cellular Energy. For what NAD+ does more broadly in the cell, see What Does NAD+ Do?. For why compartment matters, see NAD+ Compartmentalization.
- NAD+/NADH and NADP+/NADPH are separate redox couples that are not interchangeable.
- NAD+/NADH is central to catabolic energy pathways; NADP+/NADPH powers biosynthesis and antioxidant defense.
- The NAD+/NADH ratio, not the raw amount, determines whether redox-dependent reactions can proceed.
- Cytosolic and mitochondrial NAD+/NADH ratios differ and are connected only indirectly, via shuttle systems.
- "Better redox balance" and "optimized cellular energy" are not defined, measurable scientific claims.
- Nikiforov A, Kulikova V, Ziegler M. The human NAD metabolome: Functions, metabolism and compartmentalization. Critical Reviews in Biochemistry and Molecular Biology. 2015. PMID: 25837229.
- TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nature Metabolism. 2023. PMID: 37612403.Confirmed: NADPH generated via oxidative PPP, used for reductive biosynthesis and antioxidant defense.
- Xie N, Zhang L, Gao W, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy. 2020. PMID: 33028824.